Infinity to Present At Upcoming Conferences
03 mars 2009 12h30 HE
|
Infinity Pharmaceuticals, Inc.
CAMBRIDGE, Mass., March 3, 2009 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced that management will...
Infinity Well-Financed to Achieve 'I4 2012' Long-Term Goals; Announces 2008 Financial Results
09 févr. 2009 16h00 HE
|
Infinity Pharmaceuticals, Inc.
CAMBRIDGE, Mass., Feb. 9, 2009 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today reiterated its "I4 2012" goals and...
Infinity Announces Hedgehog Pathway Preclinical Data in Ovarian Cancer
09 févr. 2009 14h45 HE
|
Infinity Pharmaceuticals, Inc.
CAMBRIDGE, Mass., Feb. 9, 2009 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced the presentation of...
Infinity Announces Conference Call Discussing Fourth Quarter 2008 Results
02 févr. 2009 17h45 HE
|
Infinity Pharmaceuticals, Inc.
CAMBRIDGE, Mass., Feb. 2, 2009 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced that Infinity management...
Infinity Announces 2009 and Long-Term Goals, Building On 2008 Success
12 janv. 2009 06h00 HE
|
Infinity Pharmaceuticals, Inc.
Begins 2009 With Four Years of Capital, Three Clinical Candidates
in Development, Two New INDs, and One Pivotal Trial
Introduces "I4 2012" Long-Term Goals
CAMBRIDGE,...
Infinity Announces Completion of Second Equity Investment by Purdue
08 janv. 2009 08h03 HE
|
Infinity Pharmaceuticals, Inc.
CAMBRIDGE, Mass., Jan. 8, 2009 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, announced that its shareholders have voted...
Infinity to Present At JP Morgan Healthcare Conference
06 janv. 2009 08h30 HE
|
Infinity Pharmaceuticals, Inc.
CAMBRIDGE, Mass., Jan. 6, 2009 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced that Steven H. Holtzman,...
Infinity Reacquires Worldwide Rights to Its Hsp90 Inhibitor Program
11 déc. 2008 06h00 HE
|
Infinity Pharmaceuticals, Inc.
Infinity to Independently Develop Its Industry-Leading Hsp90 Program
Clinical Programs Continue to Advance On Schedule
CAMBRIDGE, Mass., Dec. 11, 2008 (GLOBE NEWSWIRE) -- Infinity...
Infinity to Present At Piper Jaffray 20th Annual Health Care Conference
26 nov. 2008 13h45 HE
|
Infinity Pharmaceuticals, Inc.
CAMBRIDGE, Mass., Nov. 26, 2008 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced that Adelene Q. Perkins,...
Infinity Announces Global Strategic Alliance With Purdue Pharma and Mundipharma Encompassing Infinity's Early Clinical and Discovery Programs
20 nov. 2008 06h00 HE
|
Infinity Pharmaceuticals, Inc.
Infinity Retains All U.S. Rights; Mundipharma Receives Ex-U.S.
Commercialization Rights to All Oncology Products Under Alliance
Infinity to Receive Up to $75 Million Equity...